SG11201501792RA - C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof - Google Patents
C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereofInfo
- Publication number
- SG11201501792RA SG11201501792RA SG11201501792RA SG11201501792RA SG11201501792RA SG 11201501792R A SG11201501792R A SG 11201501792RA SG 11201501792R A SG11201501792R A SG 11201501792RA SG 11201501792R A SG11201501792R A SG 11201501792RA SG 11201501792R A SG11201501792R A SG 11201501792RA
- Authority
- SG
- Singapore
- Prior art keywords
- alkanediyl
- methods
- oleanolic acid
- alkenediyl
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/47—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of rings being part of condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D305/08—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261699122P | 2012-09-10 | 2012-09-10 | |
| US201361780540P | 2013-03-13 | 2013-03-13 | |
| PCT/US2013/059027 WO2014040060A1 (en) | 2012-09-10 | 2013-09-10 | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201501792RA true SG11201501792RA (en) | 2015-05-28 |
Family
ID=49253402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201501792RA SG11201501792RA (en) | 2012-09-10 | 2013-09-10 | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof |
Country Status (38)
| Country | Link |
|---|---|
| US (2) | US9593074B2 (en) |
| EP (1) | EP2892912B1 (en) |
| JP (1) | JP6243428B2 (en) |
| KR (1) | KR102237359B1 (en) |
| CN (1) | CN104955833B (en) |
| AR (1) | AR092506A1 (en) |
| AU (1) | AU2013312106B2 (en) |
| BR (1) | BR112015005168A2 (en) |
| CA (1) | CA2882418C (en) |
| CL (1) | CL2015000543A1 (en) |
| CR (1) | CR20150117A (en) |
| CY (1) | CY1121776T1 (en) |
| DK (1) | DK2892912T3 (en) |
| DO (1) | DOP2015000054A (en) |
| EA (1) | EA029174B1 (en) |
| ES (1) | ES2731758T3 (en) |
| HK (1) | HK1212355A1 (en) |
| HR (1) | HRP20191165T1 (en) |
| HU (1) | HUE044126T2 (en) |
| IL (1) | IL237639B (en) |
| IN (1) | IN2015DN01442A (en) |
| LT (1) | LT2892912T (en) |
| ME (1) | ME03522B (en) |
| MX (1) | MX366913B (en) |
| MY (1) | MY180903A (en) |
| NZ (1) | NZ630967A (en) |
| PE (1) | PE20150627A1 (en) |
| PH (1) | PH12015500491B1 (en) |
| PL (1) | PL2892912T3 (en) |
| PT (1) | PT2892912T (en) |
| RS (1) | RS59194B1 (en) |
| SG (1) | SG11201501792RA (en) |
| SI (1) | SI2892912T1 (en) |
| TW (1) | TWI630212B (en) |
| UA (1) | UA115672C2 (en) |
| UY (1) | UY35023A (en) |
| WO (1) | WO2014040060A1 (en) |
| ZA (1) | ZA201501206B (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4923146B2 (en) | 2008-01-11 | 2012-04-25 | リアタ ファーマシューティカルズ インコーポレイテッド | Synthetic triterpenoids and methods of use in the treatment of disease |
| JP5564490B2 (en) | 2008-04-18 | 2014-07-30 | リアタ ファーマシューティカルズ インコーポレイテッド | Compounds containing anti-inflammatory pharmacores and methods of use |
| MX2010011438A (en) | 2008-04-18 | 2011-01-25 | Reata Pharmaceuticals Inc | Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17. |
| NO2651902T3 (en) | 2010-12-17 | 2018-04-07 | ||
| WO2013139766A1 (en) * | 2012-03-20 | 2013-09-26 | Firmenich Sa | Compounds for a controlled release of active perfuming molecules |
| ES2861393T3 (en) | 2012-04-27 | 2021-10-06 | Reata Pharmaceuticals Inc | 2,2-Difluoropropionamide derivatives of methyl bardoxolone, pharmaceutical compositions and polymorphs thereof for use in the treatment of certain conditions |
| US9556222B2 (en) | 2012-06-15 | 2017-01-31 | Reata Pharmaceuticals, Inc. | A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof |
| US9512094B2 (en) | 2012-09-10 | 2016-12-06 | Reata Pharmaceuticals, Inc. | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof |
| EA029174B1 (en) | 2012-09-10 | 2018-02-28 | Рита Фармасьютикалз, Инк. | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof |
| UY35534A (en) | 2013-04-24 | 2014-10-31 | Abbvie Inc | DERIVATIVES OF 2,2-DIFLUOROPROPANAMIDE AND METHYL BARDOXOLONE, POLYMODIC FORMS AND METHODS OF USE |
| US11059792B2 (en) | 2015-02-12 | 2021-07-13 | Reata Pharmaceuticals, Inc. | Imidazolyl tricyclic enones as antioxidant inflammation modulators |
| EA201890767A1 (en) | 2015-09-23 | 2019-09-30 | Рита Фармасьютикалз, Инк. | C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER APPLICATIONS |
| JP6633812B2 (en) | 2016-11-08 | 2020-01-22 | リアタ ファーマシューティカルズ インコーポレイテッド | Method of treating alport syndrome using bardoxolone methyl or analogs thereof |
| CN110248932B (en) | 2016-12-16 | 2023-03-10 | 里亚塔医药公司 | Pyrimidine tricycloalkenone derivatives for ROR γ inhibition and other uses |
| KR102295179B1 (en) | 2017-09-14 | 2021-08-30 | 피닉스 바이오테크놀러지 인코포레이티드. | Methods and compositions for the treatment of viral infections |
| KR20200083969A (en) | 2017-09-14 | 2020-07-09 | 피닉스 바이오테크놀러지 인코포레이티드. | Methods and neuroprotective compositions for treating neurological conditions |
| US9896476B1 (en) | 2017-09-21 | 2018-02-20 | King Saud University | Glycyrrhetic acid derivatives |
| CN108640965B (en) * | 2018-06-23 | 2021-11-05 | 沈阳药科大学 | 2-substituted-18 beta-glycyrrhetinic acid derivative and application thereof |
| RU2020130238A (en) | 2020-03-31 | 2022-03-14 | Феникс Байотекнолоджи, Инк. | METHOD AND COMPOSITIONS FOR TREATMENT OF CORONAVIRUS INFECTION |
| EP4009981B1 (en) | 2020-03-31 | 2023-08-16 | Phoenix Biotechnology, Inc. | Method and compositions for treating coronavirus infection |
| AU2021397631A1 (en) | 2020-12-11 | 2023-07-20 | Reata Pharmaceuticals Holdings, LLC | Synthetic triterpenoids for use in therapy |
| CN117015548A (en) * | 2021-01-18 | 2023-11-07 | 里亚塔医药公司 | Synthetic ursolic acid derivatives and methods of use thereof |
Family Cites Families (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4395423A (en) | 1978-10-10 | 1983-07-26 | Sterling Drug Inc. | Polycyclic cyanoketones |
| NZ191586A (en) | 1978-10-10 | 1981-10-19 | Sterling Drug Inc | Cyanoketones derived from glycyrrhetinic acid and pharmaceutical compositions |
| US5064823A (en) | 1988-08-24 | 1991-11-12 | Research Triangle Institute | Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers |
| US6326507B1 (en) | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
| US6369101B1 (en) | 1999-02-26 | 2002-04-09 | Regents Of The University Of Minnesota | Therapeutic method to treat herpes virus infection |
| MXPA01011613A (en) | 1999-05-14 | 2003-10-14 | Nereus Pharmaceuticals Inc | NOVEL INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-alpha MODULATORS, SYNTHESES OF SAID MODULATORS AND METHODS OF USING SAID MODULATORS. |
| US6649654B1 (en) | 1999-11-23 | 2003-11-18 | The Regents Of The University Of California | Methods for identifying and using IKK inhibitors |
| JP2001240573A (en) * | 2000-03-01 | 2001-09-04 | Meiji Seika Kaisha Ltd | Triterpene derivative and liver disease medical treatment agent |
| WO2002003996A1 (en) | 2000-07-12 | 2002-01-17 | RAJKUMAR, Sujatha | Use of dammarane-type tritepenoid saporins |
| AU2001294959A1 (en) | 2000-09-29 | 2002-04-08 | Robert M. Carlson | Triterpenes having antibacterial activity |
| JP2004509972A (en) | 2000-09-29 | 2004-04-02 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | Triterpenes with fungicidal activity against yeast |
| US6951847B2 (en) | 2000-09-29 | 2005-10-04 | Regents Of The University Of Minnesota | Methods of treating fungal infections using lupeol |
| US6878751B1 (en) | 2000-10-19 | 2005-04-12 | Imperial College Of Science Technology And Medicine | Administration of resveratrol to treat inflammatory respiratory disorders |
| US7435755B2 (en) | 2000-11-28 | 2008-10-14 | The Trustees Of Dartmouth College | CDDO-compounds and combination therapies thereof |
| CA2430454A1 (en) | 2000-11-28 | 2002-06-20 | Board Of Regents, The University Of Texas System | Cddo-compounds and combination therapies thereof |
| US20040234977A1 (en) | 2001-05-14 | 2004-11-25 | Da-Wei Gong | Novel alanine transaminase enzyme and methods of use |
| CA2472581C (en) | 2002-01-15 | 2012-06-26 | Trustees Of Dartmouth College | Tricyclic-bis-enone derivatives and methods of use thereof |
| CA2473799A1 (en) | 2002-01-18 | 2003-07-31 | Regents Of The University Of Minnesota | Triterpene quaternary salts as biologically active surfactants |
| EP1507541A4 (en) | 2002-05-13 | 2009-06-03 | Dartmouth College | Inhibitors and methods of use thereof |
| WO2004089357A2 (en) | 2003-04-02 | 2004-10-21 | Regents Of The University Of Minnesota | Anti-fungal formulation of triterpene and essential oil |
| WO2005042002A2 (en) | 2003-10-30 | 2005-05-12 | Entelos, Inc. | Treatment of rhematoid arthritis with flip antagonists |
| WO2005046732A2 (en) | 2003-11-04 | 2005-05-26 | THE UNITED SATES OF AMERICA as represented by THE SECRETARY OF HEALTH AND HUMAN SERVICES, NIH | Methods and compositions for the inhibition of hiv-1 replication |
| US20060258752A1 (en) | 2004-02-12 | 2006-11-16 | Vander Jagt David L | Method and compounds for cancer treatment utilizing NFkB as a direct or ultimate target for small molecule inhibitors |
| JP2005314381A (en) | 2004-03-30 | 2005-11-10 | Anges Mg Inc | Prophylactic/therapeutic/ameliorating agent for proliferative nephropathy |
| EP1811840B1 (en) | 2004-09-07 | 2016-04-13 | May Sung Mak | Anti-tumor compounds with angeloyl groups |
| EP1959969A2 (en) | 2005-07-01 | 2008-08-27 | The Johns Hopkins University | Compositions and methods for the treatment or prevention of disorders relating to oxidative stress |
| JP2009530405A (en) | 2006-03-23 | 2009-08-27 | アドバンスト ライフ サイエンシズ インコーポレイテッド | Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin |
| WO2007127791A2 (en) | 2006-04-25 | 2007-11-08 | The Administrators Of The Tulane Educational Fund | New pharmacological method for treatment of neuropathic pain |
| US8389573B2 (en) | 2006-06-27 | 2013-03-05 | Wellington Laboratories Inc. | Glycyrrhetinic acid derivatives |
| CN101117348B (en) | 2006-08-01 | 2010-12-29 | 浙江海正药业股份有限公司 | A and C macrocyclic oxidation substituted pentacyclic triterpanoids and preparation method and use thereof |
| JP2008110962A (en) | 2006-08-02 | 2008-05-15 | Santen Pharmaceut Co Ltd | PREVENTING OR TREATING AGENT OF KERATOCONJUNCTIVAL TROUBLE, CONTAINING Nrf2-ACTIVATING SUBSTANCE AS ACTIVE INGREDIENT |
| WO2008016095A1 (en) | 2006-08-02 | 2008-02-07 | Santen Pharmaceutical Co., Ltd. | PREVENTIVE OR REMEDY FOR KERATOCONJUNCTIVAL DISORDERS CONTAINING Nrf2 ACTIVATOR AS THE ACTIVE INGREDIENT |
| WO2008064132A2 (en) | 2006-11-17 | 2008-05-29 | Trustees Of Dartmouth College | Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth |
| WO2008064133A1 (en) | 2006-11-17 | 2008-05-29 | Trustees Of Dartmouth College | Synthesis and biological activities of new tricyclic-bis-enones (tbes) |
| FI2629097T1 (en) | 2007-02-08 | 2022-06-15 | Biogen Idec Inc | NRF2 screening assays and related methods and compositions |
| WO2008111497A1 (en) | 2007-03-08 | 2008-09-18 | Santen Pharmaceutical Co., Ltd. | Prophylactic or therapeutic agent for ophthalmic disease associated with oxidative stress, comprising triterpenoid as active ingredient |
| US20080254055A1 (en) * | 2007-04-11 | 2008-10-16 | John Erich Oblong | Compositions for Regulation of Hair Growth |
| WO2008136838A1 (en) | 2007-05-04 | 2008-11-13 | Trustees Of Dartmouth College | Novel amide derivatives of cddo and methods of use thereof |
| WO2009023845A2 (en) | 2007-08-15 | 2009-02-19 | The Board Of Regents Of The University Of Texas System | Combination therapy with synthetic triterpenoids and gemcitabine |
| US8088824B2 (en) | 2007-08-15 | 2012-01-03 | Reata Pharmaceuticals Inc. | Forms of CDDO methyl ester |
| US9012439B2 (en) | 2007-10-29 | 2015-04-21 | University Of Rochester | Use of electrophilic compounds for inducing platelet production or maintaining platelet function |
| JP4923146B2 (en) | 2008-01-11 | 2012-04-25 | リアタ ファーマシューティカルズ インコーポレイテッド | Synthetic triterpenoids and methods of use in the treatment of disease |
| MX2010011438A (en) | 2008-04-18 | 2011-01-25 | Reata Pharmaceuticals Inc | Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17. |
| US8071632B2 (en) | 2008-04-18 | 2011-12-06 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: novel derivatives of oleanolic acid |
| MX2010011439A (en) * | 2008-04-18 | 2011-01-25 | Reata Pharmaceuticals Inc | Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives. |
| JP5564490B2 (en) | 2008-04-18 | 2014-07-30 | リアタ ファーマシューティカルズ インコーポレイテッド | Compounds containing anti-inflammatory pharmacores and methods of use |
| US7915402B2 (en) | 2008-04-18 | 2011-03-29 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring |
| EP2309860B1 (en) | 2008-07-22 | 2014-01-08 | Trustees of Dartmouth College | Monocyclic cyanoenones and methods of use thereof |
| US8778990B2 (en) | 2008-11-04 | 2014-07-15 | Trustees Of Dartmouth College | Betulinic acid derivatives and methods of use thereof |
| JP5775464B2 (en) | 2009-02-13 | 2015-09-09 | リアタ ファーマシューティカルズ，インク | Delayed release oral dosage composition containing amorphous CDDO-ME |
| RS59850B1 (en) | 2010-04-12 | 2020-02-28 | Reata Pharmaceuticals Inc | Bardoxolone methyl for the treatment of obesity |
| WO2011140078A1 (en) | 2010-05-04 | 2011-11-10 | Concert Pharmaceuticals, Inc. | Synthetic triterpenoid derivatives |
| CN102079772A (en) | 2010-12-09 | 2011-06-01 | 中国药科大学 | Pentacyclic triterpene-13,28-lactone compounds as well as preparation method and application thereof |
| CN102070697A (en) | 2010-12-09 | 2011-05-25 | 中国药科大学 | Oleanolic acid derivative, and preparation method and purpose thereof |
| NO2651902T3 (en) | 2010-12-17 | 2018-04-07 | ||
| CA2826113C (en) | 2011-01-31 | 2018-09-04 | Bristol-Myers Squibb Company | C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity |
| CN102093462B (en) | 2011-02-28 | 2012-11-21 | 贵州省中国科学院天然产物化学重点实验室 | Preparation method and application of 1alpha, 2alpha-dyhydroxyl oleanolic acid |
| ES2729405T3 (en) * | 2011-03-11 | 2019-11-04 | Reata Pharmaceuticals Inc | C4-monomethyl triterpenoid derivatives and methods of use thereof |
| WO2012154554A1 (en) | 2011-05-06 | 2012-11-15 | Catabasis Pharmaceuticals, Inc. | Fatty acid triterpene derivatives and their uses |
| CN102250189B (en) | 2011-05-20 | 2012-08-29 | 中国药科大学 | Glycyrrhetic acid derivative with 1, 12-diene-3-ketone skeleton, its preparation method and medicinal uses |
| ES2861393T3 (en) | 2012-04-27 | 2021-10-06 | Reata Pharmaceuticals Inc | 2,2-Difluoropropionamide derivatives of methyl bardoxolone, pharmaceutical compositions and polymorphs thereof for use in the treatment of certain conditions |
| WO2013169740A2 (en) | 2012-05-08 | 2013-11-14 | Trustees Of Dartmouth College | Synthetic triterpenoids and methods for modulating stem/progenitor cell gene expression |
| US8921419B2 (en) | 2012-05-08 | 2014-12-30 | Trustees Of Dartmouth College | Triterpenoids and compositions containing the same |
| US8981144B2 (en) | 2012-05-08 | 2015-03-17 | Trustees Of Dartmouth College | Method for synthesizing 2-cyano-3,12-dioxoolean-1, 9(11)-dien-28-oic acid methyl ester and derivatives thereof |
| DK2855435T3 (en) | 2012-05-29 | 2018-07-16 | Parion Sciences Inc | DENDRIMER-LIKE AMINOAMIDES WITH SODIUM CHANNEL BLOCKING ACTIVITY FOR THE TREATMENT OF DRY EYES AND OTHER MILK DISEASES |
| US9556222B2 (en) | 2012-06-15 | 2017-01-31 | Reata Pharmaceuticals, Inc. | A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof |
| ES2644615T3 (en) | 2012-09-10 | 2017-11-29 | Reata Pharmaceuticals, Inc. | C17 heteroaryl derivatives of oleanolic acid and their methods of use |
| EP2892910B1 (en) | 2012-09-10 | 2016-09-07 | AbbVie Inc. | Glycyrrhetinic acid derivatives with anti-inflammatory activity |
| US9512094B2 (en) | 2012-09-10 | 2016-12-06 | Reata Pharmaceuticals, Inc. | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof |
| WO2014040073A1 (en) | 2012-09-10 | 2014-03-13 | Reata Pharmaceuticals, Inc. | C13-hydroxy derivatives of oleanolic acid and methods of use thereof |
| AU2013311705A1 (en) | 2012-09-10 | 2015-02-05 | F. Hoffmann-La Roche Ag | 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of Hepatitis B virus infection |
| EA029174B1 (en) | 2012-09-10 | 2018-02-28 | Рита Фармасьютикалз, Инк. | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof |
| WO2014048033A1 (en) | 2012-09-28 | 2014-04-03 | Applied Pharmaceutical Science, Inc. | Polymorphs of cddo ethyl ester and uses thereof |
| CN102887936A (en) | 2012-10-24 | 2013-01-23 | 苏州晶云药物科技有限公司 | Crystal forms of 2-cyano-3,12-dioxoolean-1,9(11)-diene-28-oic acid methyl ester |
| CN103788166A (en) | 2012-10-30 | 2014-05-14 | 中国药科大学 | Delta<13(18)>-CDDO derivative, its preparation method and its use in pharmacy |
| UY35534A (en) | 2013-04-24 | 2014-10-31 | Abbvie Inc | DERIVATIVES OF 2,2-DIFLUOROPROPANAMIDE AND METHYL BARDOXOLONE, POLYMODIC FORMS AND METHODS OF USE |
| NZ756256A (en) | 2013-08-23 | 2021-07-30 | Reata Pharmaceuticals Inc | Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof |
| EA201890767A1 (en) | 2015-09-23 | 2019-09-30 | Рита Фармасьютикалз, Инк. | C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER APPLICATIONS |
-
2013
- 2013-09-10 EA EA201590540A patent/EA029174B1/en not_active IP Right Cessation
- 2013-09-10 RS RSP20190829 patent/RS59194B1/en unknown
- 2013-09-10 AU AU2013312106A patent/AU2013312106B2/en active Active
- 2013-09-10 AR ARP130103221A patent/AR092506A1/en active IP Right Grant
- 2013-09-10 CR CR20150117A patent/CR20150117A/en unknown
- 2013-09-10 UY UY0001035023A patent/UY35023A/en not_active Application Discontinuation
- 2013-09-10 BR BR112015005168A patent/BR112015005168A2/en not_active Application Discontinuation
- 2013-09-10 PL PL13767176T patent/PL2892912T3/en unknown
- 2013-09-10 LT LTEP13767176.4T patent/LT2892912T/en unknown
- 2013-09-10 ME MEP-2019-174A patent/ME03522B/en unknown
- 2013-09-10 NZ NZ630967A patent/NZ630967A/en unknown
- 2013-09-10 JP JP2015531318A patent/JP6243428B2/en active Active
- 2013-09-10 US US14/022,986 patent/US9593074B2/en active Active
- 2013-09-10 WO PCT/US2013/059027 patent/WO2014040060A1/en active Application Filing
- 2013-09-10 PT PT13767176T patent/PT2892912T/en unknown
- 2013-09-10 CN CN201380058427.0A patent/CN104955833B/en active Active
- 2013-09-10 KR KR1020157009157A patent/KR102237359B1/en active IP Right Grant
- 2013-09-10 TW TW102132641A patent/TWI630212B/en active
- 2013-09-10 SI SI201331468T patent/SI2892912T1/en unknown
- 2013-09-10 CA CA2882418A patent/CA2882418C/en active Active
- 2013-09-10 MX MX2015003079A patent/MX366913B/en active IP Right Grant
- 2013-09-10 PE PE2015000315A patent/PE20150627A1/en active IP Right Grant
- 2013-09-10 SG SG11201501792RA patent/SG11201501792RA/en unknown
- 2013-09-10 ES ES13767176T patent/ES2731758T3/en active Active
- 2013-09-10 EP EP13767176.4A patent/EP2892912B1/en active Active
- 2013-09-10 DK DK13767176.4T patent/DK2892912T3/en active
- 2013-09-10 HU HUE13767176A patent/HUE044126T2/en unknown
- 2013-09-10 IN IN1442DEN2015 patent/IN2015DN01442A/en unknown
- 2013-09-10 MY MYPI2015000568A patent/MY180903A/en unknown
- 2013-10-09 UA UAA201503335A patent/UA115672C2/en unknown
-
2015
- 2015-02-23 ZA ZA2015/01206A patent/ZA201501206B/en unknown
- 2015-03-05 CL CL2015000543A patent/CL2015000543A1/en unknown
- 2015-03-06 PH PH12015500491A patent/PH12015500491B1/en unknown
- 2015-03-09 DO DO2015000054A patent/DOP2015000054A/en unknown
- 2015-03-09 IL IL237639A patent/IL237639B/en active IP Right Grant
-
2016
- 2016-01-12 HK HK16100293.6A patent/HK1212355A1/en unknown
-
2017
- 2017-02-15 US US15/433,100 patent/US10501489B2/en active Active
-
2019
- 2019-06-27 HR HRP20191165TT patent/HRP20191165T1/en unknown
- 2019-07-02 CY CY20191100697T patent/CY1121776T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1212355A1 (en) | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof c17- | |
| HK1211295A1 (en) | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof c17- | |
| RS59200B1 (en) | C4-monomethyl triterpenoid derivatives and methods of use thereof | |
| HK1212977A1 (en) | Bendamustine derivatives and methods of using same | |
| HK1212251A1 (en) | Topical compositions and methods of use | |
| IL236965B (en) | Derivatives of 5-aminolevulinic acid and uses thereof | |
| HK1210941A1 (en) | Modified hyaluronic acid derivatives and use thereof | |
| EP2986112A4 (en) | Preparation and use of fulvic acid derivatives | |
| IL238934A0 (en) | Method for preparing phenyloxymethyl-nitro-imidazole derivatives and use of same |